Drug Enforcement D-783-2013

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Status

Ongoing

Classification

Class II

Report Date

July 17, 2013

Termination Date

Product Information

Product description
Stanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL
Product quantity
3
Reason for recall
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiation reason
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution pattern
Nationwide and PR

Location & Firm

Recalling firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Address
6700 Conroy Windermere Rd, Suite 140

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-783-2013
Event ID
65360
Recall initiation date
May 29, 2013
Center classification date
July 11, 2013
Code info
50mg/ml = Lots B5727 Exp 8/27/13, and C5708 Exp 9/8/13 // 100,g/ml =Lot C5706 Exp 9/6/13
More code info